Altrius Capital Raises Procter & Gamble Stake 11.7% to $4.87 Million

PGPG

Altrius Capital Management increased its Procter & Gamble stake by 11.7%, acquiring 3,320 additional shares to hold 31,660 shares valued at $4.87 million as of the latest SEC filing. Institutional investors now own 65.77% of P&G stock.

1. Major Institutional Stake Build-Up

Altrius Capital Management Inc boosted its holdings in Procter & Gamble by 11.7% during the third quarter, adding 3,320 shares to reach a total of 31,660 shares. This increase, valued at approximately $4.87 million, underscores growing confidence among institutional investors. Several other funds also modestly raised positions, including Orca Investment Management (up 2.0%), Sovereign Financial Group (up 1.1%) and WP Advisors (up 4.9%), contributing to a combined institutional ownership of roughly 65.8%. These accumulation trends reflect broad interest in P&G’s defensive consumer staples profile as market volatility persists.

2. Solid Quarterly Results and Upgraded Guidance

In its latest reporting period, Procter & Gamble delivered an adjusted EPS of $1.88, marginally exceeding consensus estimates, on revenue of $22.21 billion, representing 1.5% year-over-year growth. Net margin remained healthy at 19.3%, while return on equity stood at 32.2%. Management reiterated its full-year EPS guidance range of 6.83 to 7.09, suggesting confidence in stable pricing power and cost management. Investors will watch P&G’s ability to leverage innovation in beauty and personal care for margin expansion amid moderating input cost pressures.

3. Shareholder Returns and Insider Activity

The board declared a quarterly dividend of $1.0568 per share, marking the 66th consecutive annual increase and reflecting a payout ratio near 63%. This translates into a yield of approximately 2.7% on current share counts. On the insider front, Marc S. Pritchard sold 95,903 shares and CEO Ma. Fatima Francisco disposed of 8,000 shares in recent weeks, reducing their personal stakes by 34% and 55% respectively. While these sales generated over $15.7 million in proceeds, P&G insiders still retain significant equity positions, underscoring alignment with long-term shareholder value creation.

4. Analyst Sentiment and Ratings

Equity research firms have grown more positive on Procter & Gamble, with recent upgrades by Jefferies and UBS reflecting expectations for improved organic growth and margin resilience. Out of 22 analyst opinions surveyed, 13 recommend buy-or-equivalent ratings, 9 suggest hold, and consensus sentiment remains in the moderate buy category. Analysts cite accelerated innovation cycles, premiumization strategies and digital channel expansion as key catalysts for sustained earnings growth.

Sources

ZDGG